Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1973 1
1978 1
1981 1
1992 1
1993 1
1994 2
1995 4
1996 2
1998 5
2002 3
2006 1
2007 1
2008 1
2010 1
2011 2
2012 3
2013 2
2014 2
2015 2
2016 2
2017 6
2018 4
2019 7
2020 11
2021 7
2022 11
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Astrocytoma: A Hormone-Sensitive Tumor?
Hirtz A, Rech F, Dubois-Pot-Schneider H, Dumond H. Hirtz A, et al. Among authors: rech f. Int J Mol Sci. 2020 Nov 30;21(23):9114. doi: 10.3390/ijms21239114. Int J Mol Sci. 2020. PMID: 33266110 Free PMC article. Review.
Current management of ovarian endometriomas.
Muzii L, Di Tucci C, Di Mascio D, Di Feliciantonio M, Capri O, Pietrangeli D, Rech F, Benedetti Panici P. Muzii L, et al. Among authors: rech f. Minerva Ginecol. 2018 Jun;70(3):286-294. doi: 10.23736/S0026-4784.17.04180-6. Epub 2017 Dec 4. Minerva Ginecol. 2018. PMID: 29205996 Review.
Estrogen signaling in healthy and tumor brain.
Hirtz A, Rech F, Dubois-Pot-Schneider H, Dumond H. Hirtz A, et al. Among authors: rech f. Steroids. 2023 Nov;199:109285. doi: 10.1016/j.steroids.2023.109285. Epub 2023 Aug 3. Steroids. 2023. PMID: 37543222 Review.
[Placental chorioangioma].
Rech F, Salernitano D, Patella A. Rech F, et al. Minerva Ginecol. 2002 Oct;54(5):417-33. Minerva Ginecol. 2002. PMID: 12364888 Review. Italian.
Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer.
Musella A, Bardhi E, Marchetti C, Vertechy L, Santangelo G, Sassu C, Tomao F, Rech F, D'Amelio R, Monti M, Palaia I, Muzii L, Benedetti Panici P. Musella A, et al. Among authors: rech f. Cancer Treat Rev. 2018 May;66:7-14. doi: 10.1016/j.ctrv.2018.03.004. Epub 2018 Mar 23. Cancer Treat Rev. 2018. PMID: 29605737 Review.
83 results